SIGMAR1 (Sigma Non-Opioid Intracellular Receptor 1) is a gene encoding the sigma-1 receptor, a unique ligand-operated chaperone protein primarily localized to the endoplasmic reticulum (ER). The sigma-1 receptor plays critical roles in neuronal survival, calcium homeostasis, cellular stress responses, and has been implicated in several neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), and Parkinson's disease (PD) [1][2].
| Attribute |
Value |
| Symbol |
SIGMAR1 |
| Full Name |
Sigma Non-Opioid Intracellular Receptor 1 |
| Aliases |
OPRS1, ERG28, Sigma-1R |
| Chromosomal Location |
9p13.3 |
| NCBI Gene ID |
10280 |
| OMIM |
608978 |
| Ensembl ID |
ENSG00000147955 |
| UniProt ID |
Q9Y6D6 |
The SIGMAR1 gene spans approximately 4.5 kb on chromosome 9p13.3 and consists of multiple exons. The gene produces multiple transcript variants through alternative splicing, with variant 1 encoding the canonical 223-amino acid protein.
The sigma-1 receptor is a 25.3 kDa protein with unique structural features:
- N-terminal: Single transmembrane domain anchoring the protein to ER membranes
- C-terminal: Large cytosolic domain containing the ligand-binding site
- Oligomerization: Forms functional homooligomers
¶ Ligand-Operated Chaperone Activity
The sigma-1 receptor functions as a unique ligand-operated chaperone:
- Ligand binding: Small molecule agonists bind to the cytosolic domain, triggering conformational changes
- Chaperone activation: Enhanced protein-folding capacity under cellular stress
- Client protein interaction: Interacts with various client proteins to facilitate proper folding
Sigma-1 receptor is a key regulator of ER calcium signaling:
- IP3 receptor interaction: Modulates IP3 receptor activity to regulate calcium release
- Store-operated calcium entry (SOCE): Regulates calcium influx across the plasma membrane
- Mitochondrial calcium handling: Influences mitochondrial calcium uptake at ER-mitochondria contact sites
- Primary: Endoplasmic reticulum (ER)
- Secondary: Mitochondria-associated membranes (MAM), plasma membrane, nuclear envelope
SIGMAR1 mutations are causally linked to juvenile ALS type 16 (ALS16), characterized by:
- Autosomal recessive inheritance: Biallelic loss-of-function mutations
- Motor neuron degeneration: Progressive loss of upper and lower motor neurons
- Early onset: Symptoms typically appear in adolescence or early adulthood
The sigma-1 receptor is essential for motor neuron survival through its roles in:
- ER stress response
- Mitochondrial function
- Calcium homeostasis
- Protein quality control
In Alzheimer's disease, sigma-1 receptor activity is protective:
- Neuroprotection: Activation protects neurons against amyloid-beta (Aβ) toxicity
- Calcium regulation: Helps maintain calcium homeostasis disrupted by Aβ
- Chaperone activity: Assists in clearing misfolded proteins
- Synaptic plasticity: Supports learning and memory processes
Sigma-1 receptor modulation affects:
- Dopaminergic neuron survival: Activation protects against dopaminergic neuron degeneration
- Mitochondrial function: Maintains mitochondrial integrity in substantia nigra neurons
- Alpha-synuclein: Modulates aggregation pathways of alpha-synuclein
- Genetic link: SIGMAR1 mutations cause FTD in some families
- ER stress: Dysregulated ER stress response contributes to FTD pathology
- Protein homeostasis: Impaired protein quality control mechanisms
| Partner Protein |
Interaction Type |
Functional Outcome |
| IP3R3 |
Direct binding |
Calcium regulation |
| GRP78/BiP |
Chaperone complex |
ER stress response |
| VDAC |
Mitochondrial interaction |
Calcium homeostasis |
| Ankyrin |
Membrane anchoring |
Subcellular localization |
| PACT |
Stress-activated kinase |
Cell survival signaling |
| Compound |
Status |
Therapeutic Use |
| Donepezil |
Approved (AD) |
Acetylcholinesterase inhibitor with sigma-1 agonist activity |
| SA4503 |
Preclinical |
Selective sigma-1 agonist for neuroprotection |
| PRE-084 |
Research |
Sigma-1 agonist, promotes neurite outgrowth |
| Fluvoxamine |
Clinical |
SSRI with sigma-1 agonist properties |
- Neuroprotection: Agonists protect neurons from various insults
- Anti-inflammatory: Reduce neuroinflammation
- Anti-aggregation: Prevent pathogenic protein aggregation
- Mitochondrial support: Maintain mitochondrial function
- Knockout mice: Viable but show neurological phenotypes including motor deficits
- Transgenic models: Various ALS, AD, and PD models expressing mutant SIGMAR1
- Pharmacological studies: Demonstrated efficacy of sigma-1 agonists in disease models